يعرض 1 - 10 نتائج من 29 نتيجة بحث عن '"Boer, SM"', وقت الاستعلام: 0.78s تنقيح النتائج
  1. 1
    دورية أكاديمية

    العلاقة: pii: S0360-3016(21)02846-7; Wortman, B. G., Post, C. C. B., Powell, M. E., Khaw, P., Fyles, A., D'Amico, R., Haie-Meder, C., Jurgenliemk-Schulz, I. M., McCormack, M., Do, V., Katsaros, D., Bessette, P., Baron, M. H., Nout, R. A., Whitmarsh, K., Mileshkin, L., Lutgens, L. C. H. W., Kitchener, H. C., Brooks, S. ,. de Boer, S. M. (2022). Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 112 (2), pp.390-399. https://doi.org/10.1016/j.ijrobp.2021.09.042Test.; http://hdl.handle.net/11343/301959Test

  2. 2
    دورية أكاديمية

    العلاقة: pii: S0893-3952(22)00263-0; Vermij, L., Leon-Castillo, A., Singh, N., Powell, M. E., Edmondson, R. J., Genestie, C., Khaw, P., Pyman, J., McLachlin, C. M., Ghatage, P., de Boer, S. M., Nijman, H. W., Smit, V. T. H. B. M., Crosbie, E. J., Leary, A., Creutzberg, C. L., Horeweg, N. & Bosse, T. (2022). p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial. MODERN PATHOLOGY, 35 (10), pp.1475-1483. https://doi.org/10.1038/s41379-022-01102-xTest.; http://hdl.handle.net/11343/318238Test

  3. 3
    دورية أكاديمية

    العلاقة: pii: 10.1038/s41467-022-29040-x; Horeweg, N., Workel, H. H., Loiero, D., Church, D. N., Vermij, L., Leon-Castillo, A., Krog, R. T., de Boer, S. M., Nout, R. A., Powell, M. E., Mileshkin, L. R., MacKay, H., Leary, A., Singh, N., Juergenliemk-Schulz, I. M., Smit, V. T. H. B. M., Creutzberg, C. L., Koelzer, V. H., Nijman, H. W. ,. de Bruyn, M. (2022). Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. NATURE COMMUNICATIONS, 13 (1), https://doi.org/10.1038/s41467-022-29040-xTest.; http://hdl.handle.net/11343/307107Test

  4. 4
    مؤتمر
  5. 5
    دورية أكاديمية

    المصدر: Corbeau , A , Nout , R , Mens , J W , Horeweg , N , Godart , J , Kerkhof , E M , Kuipers , S C , van Poelgeest , M , Kroep , JR , Boere , I , van Doorn , L , Hoogeman , M , van der Heide , UA , Putter , H , Welters , MJP , van der Burg , SH , Creutzberg , CL & de Boer , SM 2021 , ' PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on ....

    وصف الملف: application/pdf

  6. 6
    دورية أكاديمية

    العلاقة: pii: S0360-3016(20)34447-3; Post, C. C. B., de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, N. P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M. H., Kitchener, H. C., Nijman, H. W., Lutgens, L. C. H. W., Brooks, S., Jurgenliemk-Schulz, I. M., Feeney, A. ,. Creutzberg, C. L. (2021). Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 109 (4), pp.975-986. https://doi.org/10.1016/j.ijrobp.2020.10.030Test.; http://hdl.handle.net/11343/280199Test

  7. 7
    دورية أكاديمية

    العلاقة: pii: 6161779; Post, C. C. B., Stelloo, E., Smit, V. T. H. B. M., Ruano, D., Tops, C. M., Vermij, L., Rutten, T. A., Jurgenliemk-Schulz, I. M., Lutgens, L. C. H. W., Jobsen, J. J., Nout, R. A., Crosbie, E. J., Powell, M. E., Mileshkin, L., Leary, A., Bessette, P., Putter, H., de Boer, S. M., Horeweg, N. ,. Creutzberg, C. L. (2021). Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 113 (9), pp.1212-1220. https://doi.org/10.1093/jnci/djab029Test.; http://hdl.handle.net/11343/287915Test

  8. 8
    دورية أكاديمية

    العلاقة: pii: S1470-2045(19)30395-X; de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M. -H., Jurgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Gribaudo, S., Provencher, D. ,. Creutzberg, C. L. (2019). Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. LANCET ONCOLOGY, 20 (9), pp.1273-1285. https://doi.org/10.1016/S1470-2045Test(19)30395-X.; http://hdl.handle.net/11343/250027Test

  9. 9
    دورية أكاديمية

    المصدر: Wortman , BG , Creutzberg , CL , Putter , H , Jurgenliemk-Schulz , IM , Jobsen , JJ , Lutgens , L , van de Steen-Banasik , EM , Mens , J W , Slot , A , Kroese , MCS , van Triest , B , Nijman , HW , Stelloo , E , Bosse , T , Boer , SM , van Putten , WLJ , Smit , V & Nout , RA 2018 , ' Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy ' , British ....

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية